National Association of Testing Authorities, Australia
Scope of Accreditation
Douglass Hanly Moir Pathology
Site
North Ryde Laboratory
Accreditation No.
2178
Site No.
2171
Date of Accreditation
16 Apr 1987
Contact
Ms Tuyen Chieu
P: +61 (02) 98556042
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Anatomical Pathology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue; Fresh tissue; Smears | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in-situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue; Smears; Tissue imprint | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Fixed cytological smears; Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue; Frozen tissue | Detection of antigenic targets - Various |
CAL/Biochemistry
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of calculus | Renal calculi | Calcium |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma | Ethanol |
| Chemical pathology - Biogenic amines | Urine | 4-Hydroxy-3-methoxymethamphetamine (HMMA); 5-Hydroxyindoleacetic acid (5-HIAA); Adrenaline; Dopamine; Noradrenaline |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Sirolimus; Tacrolimus |
| Serum | Carbamazepine; Gentamicin (cidomycin, septopal, genticyn, garamycin); Phenobarbitone; Phenytoin (dilantin); Primidone; Theophylline; Tobramycin; Valproate (valproic acid, epilim); Vancomycin | |
| Carbamazepine; Digoxin; Lithium; Phenytoin (dilantin); Valproate (valproic acid, epilim) | ||
| Serum; Urine | Nicotine | |
| Chemical pathology - Detection and/or quantitation of tumour markers | Serum | Thyroglobulin |
| CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9) | ||
| CA125 antigen (CA125); Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); Prostate specific antigen (PSA) fractions and derived index; α-Fetoprotein (AFP) | ||
| Human chorionic gonadotropin (hCG) | ||
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Serum | 17α-Hydroxyprogesterone; Androstenedione |
| Adrenocorticotropic hormone (ACTH); Cortisol; Gastrin; Growth hormone | ||
| Parathyroid hormone (PTH); Procalcitonin; Prolactin; Sex hormone binding globulin (SHBG); Testosterone | ||
| Dehydroepiandrosterone sulfate (DHEAS); Follicle stimulating hormone (FSH); Insulin; Luteinising hormone (LH); Oestradiol; Progesterone | ||
| Urine | Cortisol | |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Serum | Fructosamine | |
| Chemical pathology - Further investigation of cardiac function | Serum | Troponin T |
| N-Terminal-pro b-type natriuretic peptide (NT-proBNP) | ||
| Creatine kinase MB (CKMB) | ||
| Troponin I | ||
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Serum | HDL - Quantitation; Lipoprotein subclasses |
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Bile acids - Quantitative |
| Alkaline phosphatase (ALP) isoenzymes | ||
| Caeruloplasmin; Haptoglobins; α1-Antitrypsin | ||
| Lactate dehydrogenase (LDH) isoenzymes | ||
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Serum | Myoglobin |
| Serum; Urine | β2-Microglobulin (B2M) | |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Protein - Total |
| Plasma | Ammonia; Glucose; Lactate | |
| Serum | Angiotensin converting enzyme (ACE) | |
| Bilirubin - Any fractions; Cholinesterase; Creatinine | ||
| Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - LDL; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | ||
| Serum; Urine | Osmolality | |
| Urine | Albumin; Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Albumin; Amylase; Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | ||
| Chemical pathology - Investigation for folate deficiency | Blood; Serum | Folate |
| Chemical pathology - Investigation of Helicobacter pylori colonisation or eradication | Breath | C14 |
| Chemical pathology - Investigation of malabsorption | Faeces | Faecal fat |
| Chemical pathology - Iron studies | Blood | Zinc protoporphyrin (ZPP) |
| Serum | Iron; Transferrin; Transferrin - Iron saturation percentage (%) | |
| Ferritin | ||
| Chemical pathology - Markers of bone metabolism | Urine | Deoxypyridinoline (DPD) |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma | Homocysteine |
| Chemical pathology - Quantitation of vitamin B markers | Serum | Holotranscobalamin (active vitamin B12) |
| Chemical pathology - Quantitation of vitamins | Serum | Vitamin D |
| Cobalamin (vitamin B12) | ||
| 25-Hydroxyvitamin D3 | ||
| Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Chemical pathology - Trace element analysis | Blood | Lead |
| Serum | Copper; Zinc | |
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Rheumatoid factor |
| Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) | ||
| Anti-double stranded DNA antibodies (dsDNA) | ||
| Anti-thyrotropin receptor antibodies (TSHR) | ||
| Immunopathology - Quantitation of complement proteins | Serum | Complement components C3 and C4 |
| Complement components C3 and C4 | ||
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Serum | Detection and quantitation of free kappa and free lambda light chains |
| Detection and quantitation of free kappa and free lambda light chains | ||
| Serum; Urine | Protein classes | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Immunoglobulin subclasses | ||
| Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M | ||
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
| Urine | Human chorionic gonadotropin (hCG) - Quantitative total | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Anti-streptolysin O (ASOT) |
Cytopathology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Cervical smear; Cervical tissue; Liquid based cytology specimens from cervix | Cytological examination; Review and reporting of cervical cytological material |
| Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Endometrial pipelle; Liquid based cytology specimens from cervix; Vaginal smears; Vaginal tissue; Vault smears; Vulval smears | Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Ocular specimens; Other body fluids; Sputum; Urine; Vitreous specimens; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Cytopathology - Testing for the National Cervical Screening Program | Liquid based cytology specimens from cervix | Human papilloma virus (HPV); Cytological examination; Review and reporting of cervical cytological material |
| Self collected swab samples | Human papilloma virus (HPV) |
Division of Toxicology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Urine | Synthetic cannabis |
| 6-Acetylmorphine; Buprenorphine; Codeine; Fentanyl; Morphine; Opiates; Opioids; Oxycodone; Oxymorphone; Propoxyphene; Tramadol | ||
| Buprenorphine; Methadone; Oxycodone; Phencyclidine; Propoxyphene |
ISO/IEC 17025 (2017)
Legal
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Medico legal drug testing AS/NZS 4308, appendix A On-site screening procedure - Testing performed at client sites | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Creatinine; Opiates; pH |
| Medico legal drug testing AS/NZS 4308, section 2 Specimen collection, storage, handling and dispatch | Urine | Colour; Creatinine; Temperature; pH |
| Medico legal drug testing AS/NZS 4308, section 3 General laboratory requirements | Urine | General laboratory requirements as described in AS/NZS 4308 |
| Medico legal drug testing AS/NZS 4308, section 4 Laboratory screening procedures | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Creatinine; Urea; pH |
| Medico legal drug testing AS/NZS 4308, section 5 Laboratory confirmatory procedures | Urine | 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Diazepam; Nordiazepam; Oxazepam; Temazepam; α-Hydroxyalprazolam |
| 11-nor-δ-9-Tetrahydrocannabinol-9-carboxylic acid; 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; Amphetamines; Benzoylecgonine (ecgonine benzoate); Codeine; Ecgonine methyl ester; Ephedrine; Fentanyl; Methylamphetamine; Morphine; Oxycodone; Oxymorphone; Phentermine; Propoxyphene; Pseudoephedrine (PSE); Tramadol | ||
| Medico legal drug testing AS/NZS 4760, appendix A On-site screening test procedure | Oral fluid | Amphetamine type substances; Cocaine; Cocaine metabolites; Opiates; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
| Medico legal drug testing AS/NZS 4760, appendix B Additional testing | Oral fluid | Benzodiazepines |
| Medico legal drug testing AS/NZS 4760, section 2 Collection, storage, handling and dispatch | Oral fluid | Handling and dispatch; Sample collection and storage |
| Medico legal drug testing AS/NZS 4760, section 3 General laboratory requirements | Oral fluid | General laboratory requirements as described in AS/NZS 4760 |
| Medico legal drug testing AS/NZS 4760, section 4 Laboratory screen testing | Oral fluid | Amphetamine type substances; Cocaine; Cocaine metabolites; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
| Medico legal drug testing AS/NZS 4760, section 5 Laboratory confirmatory procedures | Oral fluid | 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; Alprazolam; Amphetamines; Benzoylecgonine (ecgonine benzoate); Clonazepam; Cocaine; Codeine; Diazepam; Ecgonine methyl ester; Methylamphetamine; Morphine; Nitrazepam; Nordiazepam; Oxazepam; Oxycodone; Temazepam; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
Eastwood Collection Centre
ISO/IEC 17025 (2017)
Legal
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Medico legal drug testing AS/NZS 4308, appendix A On-site screening procedure | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Creatinine; pH |
| Medico legal drug testing AS/NZS 4760, appendix A On-site screening test procedure | Oral fluid | Amphetamine type substances; Cocaine; Cocaine metabolites; Opiates; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
Faecal Occult Blood Testing Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection and/or quantitation of tumour markers - Testing for the National Bowel Cancer Screening Program | Faeces | Blood |
Haematology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Diagnosis of thalassemia | Blood | Haemoglobin H (HbH) inclusions |
| Haemoglobin A2 (HbA2) - Quantitation | ||
| Haematology - Examination of blood films by special staining | Blood | Morphology |
| Heinz bodies | ||
| Malaria; Parasites | ||
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Presence of foetal red blood cells |
| Detection and quantitation of foetal red cell antigens | ||
| Haematology - Full blood examination | Blood | Reticulocytes |
| Morphology | ||
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Nucleated red blood cells (NRBC); Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet function (PFA) |
| Plasma | Factor XIII | |
| Collagen binding activity | ||
| Activated partial thromboplastin time (APTT); Activated protein C (APC) resistance; Anti-Xa activity; Anti-thrombin III; D-dimer; Dabigatran; Factor II; Factor IX; Factor IX inhibitor; Factor V; Factor VII; Factor VIII; Factor VIII inhibitor; Factor X; Factor XI; Factor XII; Factor XIII; Fibrinogen; International normalised ratio (INR); Lupus anticoagulant; Protein C and protein S; Prothrombin time (PT); Thrombin time (TT); Von Willebrand factor (vWF) activity - Ristocetin co-factor assay; Von Willebrand factor (vWF) antigen - Quantitation | ||
| Serum | Heparin induced thrombotic thrombocytopenia (HITT) | |
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin S (HbS) - Presence |
| Other abnormal haemoglobins | ||
| Haematology - Investigation of haemolysis | Blood | Paroxysmal nocturnal haemoglobinuria (PNH) screen |
| Urine | Haemosiderin | |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Aspirates; Blood; Bone marrow; Disaggregated tissues specimen | 7-Aminoactinomycin (7-AAD); Assessment of lymphoid cell populations; Assessment of myeloid cell populations; CD10; CD103; CD117; CD11b; CD11c; CD123; CD13; CD138; CD14; CD15; CD158a; CD158b; CD158e; CD158k; CD16; CD161; CD19; CD2; CD20; CD23; CD24; CD25; CD27; CD28; CD3; CD300e (IREM-2); CD34; CD38; CD4; CD45; CD5; CD56; CD57; CD59; CD64; CD7; CD8; CD94; Fluorescein-labelled proaerolysin (FLAER); HLA-DR antigen; Kappa light chains; Lambda light chains; Natural killer (NK) cells; T-cell receptor aβ (TCRab); γ,δ-T-cell receptor |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Plasmodium falciparum; Plasmodium vivax |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
Immunohaematology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Haematology - Investigation of haemolysis | Blood | Cold agglutinins |
| Immunohaematology - Blood group antibody detection | Blood | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody titration |
| Antibody elution | ||
| Other blood group antibodies; Red blood cell phenotyping; Rh | ||
| Direct antiglobulin test (DAT, direct Coombs test) |
Immunoserology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Tryptase |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-endomysial antibodies (EMA); Anti-liver-kidney microsomes antibodies (LKM); Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-nuclear antibodies (ANA); Anti-skin basement membrane antibodies |
| Anti-cardiolipin antibodies (ACA); Anti-chromatin antibodies; Anti-extractable nuclear antigen antibodies (ENA); Anti-gliadin antibodies (AGA); Anti-glomerular basement membrane antibodies (anti-GBM); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3); Anti-tissue transglutaminase antibodies (tTG); Anti-β2-glycoprotein-I antibodies | ||
| Anti-Saccharomyces cerevisiae antibodies (ASCA); Anti-cyclic citrullinated peptide antibodies (CCP) | ||
| Anti-extractable nuclear antigen antibodies (ENA); Anti-ganglioside antibodies; Anti-neuronal antibodies | ||
| Bullous dermatoses | ||
| Anti-intrinsic factor antibodies (IF) | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing (purified native and/or recombinant allergens)) | Serum | Api m1 phospholipase A2 - Honey bee; Ara h1 - Peanut; Ara h2 - Peanut; Ara h3 - Peanut; Ara h8 - Peanut; Ara h9 - Peanut; Casein - Milk; Galactose-α-1,3-galactose thyroglobulin - Bovine; MUXF3 CCD; Omega-5-gliadin - Wheat; Ovomucoid - Egg; α-Lactalbumin - Milk; β-Lactoglobulin - Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Tetanus toxoid; Amoxicillin; Ampicilloyl group; Cefaclor; Chlorhexidine; Chymopapain; Gelatin - Bovine; Insulin - Human; Morphine; Penicilloyl G; Penicilloyl V; Pholcodine; Suxamethonium (succinylcholine) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Animal mix; Budgerigar droppings; Budgerigar feathers; Budgerigar serum; Caged bird mix; Canary bird droppings; Canary bird feathers; Canary bird serum; Cat epithelium; Cat serum; Chicken droppings; Chicken feathers; Chicken serum proteins; Cow dander; Dog dander; Dog epithelium; Dog serum; Duck feathers; Feather mix; Finch feathers; Goat epithelium; Goose feathers; Guinea pig epithelium; Hamster epithelium; Horse dander; Mouse epithelium; Mouse serum proteins; Mouse urine proteins; Parakeet droppings; Parakeet feathers; Parakeet serum; Parrot feathers; Pigeon droppings; Pigeon feathers; Rabbit epithelium; Rabbit urine proteins; Rat epithelium; Rat serum proteins; Rat urine proteins; Sheep epithelium; Swine epithelium; Swine serum; Turkey feathers |
| Cat dander; Cat epithelium; Dog dander; Dog epithelium; Horse dander; Horse epithelium; Mouse epithelium; Mouse serum proteins; Mouse urine proteins | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [additives] allergens) | Serum | Carob (E410); Cochineal extract (carmine red, E120) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Chicken; Egg; Egg white; Egg yolk; Turkey meat |
| Chicken; Egg; Egg white; Egg yolk | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Codfish; Shrimp |
| Abalone; Anchovy; Blue mussel; Catfish; Chub mackerel; Clam; Codfish; Crab; Crayfish; Eel; Grouper; Gulf flounder; Haddock; Hake; Halibut; Herring; Jack mackerel; Langust (spiny lobster); Lobster; Mackerel; Megrim; Octopus; Orange roughy; Oyster; Pollock; Prawn; Red snapper; Salmon; Sardine (pilchard); Scallop; Seafood mix; Shrimp; Snail; Sole; Squid; Swordfish; Tilapia; Trout; Tuna; Walleye pike; Whitefish (Inconnu) | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Apple; Celery; Kiwi; Peach |
| Apple; Apricot; Asparagus; Aubergine (eggplant); Avocado; Bamboo shoot; Banana; Beetroot; Blackberry; Blueberry; Broccoli; Brussel sprouts; Cabbage; Carrot; Cauliflower; Celery; Cherry; Cucumber; Date; Fig; Fruit mix; Garlic; Grape; Grapefruit; Jack fruit; Kiwi; Lemon citrus; Lettuce; Lime citrus; Lychee; Mandarin (tangerine, clementine, satsumas) citrus; Mango; Melon; Olive - Black, fresh; Onion; Orange citrus; Papaya; Passion fruit; Peach; Pear; Persimon (kaki fruit, sharon); Pineapple; Plum; Potato; Pumpkin; Raspberry; Red currant; Rose hip; Spinach; Strawberry; Sweet potato; Tomato; Vegetable mix; Watermelon | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Beef; Galactose-α-1,3-galactose thyroglobulin - Bovine; Horse; Lamb; Meat mix; Pork; Rabbit |
| Galactose-α-1,3-galactose thyroglobulin - Bovine | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Cow milk |
| Casein; Cheese - Cheddar type; Cheese - Mould type; Cow’s whey; Goat milk; Milk; Sheep milk; Sheep whey | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Baker's yeast; Brewer’s yeast; Cacao; Chocolate; Coffee; Honey; Hop (fruit cone); Malt; Mushroom; Staple food mix; Tea; Yeasts |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Brazil nut; Buck wheat; Cashew nut; Hazelnut; Peanut; Sesame seed; Soy bean; Walnut; Wheat |
| Almond; Barley; Brazil nut; Buck wheat; Cashew nut; Cereal mix; Chick pea; Coconut; Common millet; Corn; Fenugreek; Foxtail; Gluten; Green bean; Hazelnut; Japanese millet; Lentil; Lima bean; Linseed; Lupin seed; Macadamia nut; Nut panel; Oat; Pea; Peanut; Pecan nut; Pinenut; Pistachio; Poppy seed; Pumpkin seed; Quinoa; Rapeseed; Red kidney bean; Rice; Rye; Sesame seed; Soy bean; Spelt wheat; Sunflower seed; Walnut; Wheat; White bean | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [spices] allergens) | Serum | Allspice; Anise; Basil; Bay leaf; Black pepper; Cardamon; Chilli pepper; Cinnamon; Clove; Coriander (cilantro); Curry; Fennel seed; Ginger; Green pepper - Unripe seed; Lovage; Marjoram; Mint; Mustard; Oregano; Paprika (sweet pepper); Parsley; Saffron; Sage; Spice mix; Tarragon; Thyme; Vanilla |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bermuda grass; Timothy grass |
| Bahia grass; Bermuda grass; Brome grass; Canary grass; Couch grass; Cultivated oat; Cultivated rye; Cultivated wheat; Grass mix; Johnson grass; Kentucky plane (June) grass; Meadow fescue; Meadow foxtail; Perennial rye grass; Redtop; Salt grass; Sweet vernal grass; Timothy grass; Velvet grass; Wild rye grass | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | American cockroach; Berlin beetle; Blood worm; Cockroach; Fire ant; Grain weevil; Green nimitti; Horse fly Tabanus spp.; Mediterranean flour moth; Mosquito; Moth; Oriental cockroach |
| Cockroach | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Acremonium kiliense; Alternaria alternata; Alternaria tenius; Anisakis; Ascaris spp. (roundworm); Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Aspergillus terreus; Aureobasidium pullulans; Botrytis cinerea; Candida albicans; Cladosporium herbarum; Curvularia lunata; Echinococcus spp.; Epicoccum purpurascens; Fusarium verticillioides (Fusarium moniliforme); Malassezia spp.; Mucor racemosus; Penicillium chrysogenum (formerly Penicillium notatum); Phoma betae; Pityrosporum orbiculare (Malassezia furfur); Rhizopus nigricans; Setomelanomma rostrata (Helminthosporium halodes); Staphylococcus enterotoxins; Stemphylium herbarum; Tilletia tritici; Trichoderma viride; Trichophyton interdigitale; Trichophyton rubrum; Trichosporon pullulans; Ulocladium chartarum |
| Alternaria alternata; Anisakis; Aspergillus fumigatus; Cladosporium herbarum | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential miscellaneous allergens) | Serum | Albumin - Bovine; Cotton; Fish feed; Lactoferrin - Bovine; Seminal fluid; Tobacco leaf |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Acarus siro storage mite; Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Dermatophagoides microceras house dust mite; Dermatophagoides pteronyssinus house dust mite; Euroglyphus mayne house dust mite; Glycyphagus domesticus storage mite; Lepidoglyphus destructor storage mite; Tyrophagus putrescentiae storage mite; House dust - Greer; House dust mite mix |
| Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite; Lepidoglyphus destructor storage mite | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Latex |
| Ficus spp.; Castor bean; Chloramine-T; Cotton seed; Formaldehyde/formalin; Green coffee bean; Hexamethylene diisocyanate (1,6-hexamethylene diisocyanate; 1,6-HDI); House dust; Inhalant panel; Latex; Maleic anhydride; Methylene diphenyl diisocyanate (MDI, isocyanate MDI, diphenylmethane diisocyanate); Mould mix; Oxirane (ethyleneoxide); Pepsin; Phthalic anhydride; Psyllium (ispaghula); Rape (canola); Reactant chemicals mix; Silk; Silk waste; Tetrahydrophtalic anhydride; Toluene-2,4-diisocyanate (2,4-TDI); Trimellitic anhydride; Wool; α-Amylase | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Alder; Cypress; Hazel; Japanese cedar; Olive; Plane tree; Silver birch |
| Acacia; Alder; American beech; Australian pine; Box-elder; Cedar; Chestnut; Cottonwood; Cypress; Date; Elm; Eucalyptus; Horse chestnut; Italian/Mediterranean/funeral cypress; Japanese cedar; Melaleuca; Mountain cedar; Oak; Oil palm; Pine; Privet; Recombinant birch profilin; Red cedar; Silver birch; Sweet gum; Sycamore; Tree mix; Virginia live oak; Walnut; White ash; White pine; Willow salix | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Bee venom; Bumblebee venom; Common wasp (yellow jacket) venom; European hornet venom; European paper wasp venom; Honey bee venom; Paper wasp venom; White-faced hornet venom; Yellow hornet venom |
| Common wasp (yellow jacket) venom; Honey bee venom; Paper wasp venom | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Annual mercury; Common ragweed; Goosefoot; Mugwort; Plantain - English; Saltwort (prickly); Wall pellitory |
| Careless weed; Cocklebur; Common pigweed; Common ragweed; Dandelion; False ragweed; Flower mix; Giant ragweed; Goldenrod; Lamb’s quarters; Lupin; Mugwort; Ox-eye daisy; Plantain - English; Rough marshelder; Russian thistle; Scale; Sheep sorrel; Sunflower; Wall pellitory; Weed mix; Western ragweed; Wormwood | ||
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Serum | Eosinophil cationic protein |
| Cryoglobulins | ||
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin E |
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) antibody |
| Serum | Syphilis Treponema pallidum antibody | |
| Hepatitis C virus (HCV) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgM antibody | ||
| Barmah forest virus total antibody; Chlamydia spp.; Coxiella burnetii (Q-fever) total antibody; Dengue virus IgG antibody; Dengue virus IgM antibody; Dengue virus NS1 antigen; Ross River virus; Schistosoma mansoni | ||
| Cytomegalovirus (CMV); Cytomegalovirus (CMV) IgG avidity; Cytomegalovirus antibody (anti-CMV) IgM; Helicobacter pylori; Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Quantitative; Hepatitis C virus (HCV); Hepatitis C virus antibody (anti-HCV); Human T-lymphotropic virus type I/II (HTLV-I/II); Human immunodeficiency virus (HIV); Rubella IgG antibody; Syphilis Treponema pallidum antibody; Toxoplasma spp. IgG antibody; Toxoplasma spp. IgM antibody; Toxoplasma; Toxoplasma activity index | ||
| Bordetella pertussis IgA; Bordetella pertussis IgG; Chlamydial spp. IgG antibody; Epstein-Barr virus nuclear antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgM antibody; Herpes simplex virus (HSV); Herpes simplex virus type 1 antibody (anti-HSV1) - IgM; Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex virus type 2 antibody (anti-HSV2) - IgM; Herpes simplex type 1 antibody (anti-HSV1) - IgG; Measles IgG antibody; Measles IgM antibody; Mumps virus IgG antibody; Mumps virus IgM antibody; Mycoplasma pneumoniae; Parvovirus B19 IgG antibody; Parvovirus B19 IgM antibody; Rubella IgM antibody; Varicella zoster virus IgG antibody; Varicella zoster virus IgM antibody | ||
| Cryptococcus spp. | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) antibody |
Microbiology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) | Semen | Morphology; Motility; Sperm number |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Bacterial isolates | Bacteria; Pathogenic microorganisms |
| Blood | Bacteria; Cultured pathogens identification; Pathogenic microorganisms | |
| Bacteria; Cultured pathogens identification; Pathogenic microorganisms | ||
| Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; Sputum; Tissues; Urine; Wound swabs | Bacteria; Pathogenic identification and antibiotic susceptibility | |
| Bacteria; Cultured pathogens identification; Pathogenic microorganisms | ||
| Bacteria; Pathogenic identification and antibiotic susceptibility | ||
| Blood; Cerebrospinal fluid (CSF); Fluids; Genital specimens; Nasal swabs; Pus; Sputum; Urine; Wound swabs | Bacteria; Pathogenic identification and antibiotic susceptibility | |
| Cerebrospinal fluid (CSF); Urine | Legionella antigen | |
| Streptococcus pneumoniae | ||
| Urine | Bilirubin; Blood; Glucose; Ketones; Leucocytes (white blood cells, WBC); Nitrite; Proteins; Urobilinogen; pH | |
| Bacteria; Pathogenic microorganisms | ||
| Microbiology - Environmental investigations and/or infection control | Spore strips | Bacterial growth - Sterility |
| Vascular catheter tips | Bacterial growth - Sterility | |
| Bacterial growth - Sterility | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Axilla swabs; Groin swabs | Methicillin resistant Staphylococcus aureus (MRSA); Methicillin susceptible Staphylococcus aureus (MSSA) |
| Nasal swabs | Methicillin resistant Staphylococcus aureus (MRSA); Methicillin susceptible Staphylococcus aureus (MSSA) | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Blood | Mycobacteria identification |
| Mycobacteria identification | ||
| Microbiology - Mycology - Detection, isolation and identification of yeasts and fungal elements | Isolates | Yeasts identification |
| Nails; Skin scrapings; Tissues | Fungi identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cryptosporidia; Giardia spp. |
| Cysts; Ova; Parasites | ||
| Cryptosporidia; Giardia spp. | ||
| Microbiology - Virology - Detection of pathogenic viruses | Faeces | Norovirus |
| Adenovirus; Rotavirus |
Molecular Biology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Aspirates; Nasal swabs; Throat swabs | Bordetella pertussis |
| Faeces | Aeromonas spp.; Campylobacter spp.; Salmonella spp.; Shigella spp.; Yersinia enterocolitica | |
| Clostridiodes difficile | ||
| Genital swabs | Streptococcus agalactiae (Streptococcus group B) | |
| Genital swabs; Urine | Mycoplasma genitalium macrolide resistance; Mycoplasma genitalium | |
| Mycoplasma genitalium; Mycoplasma genitalium azithromycin resistance; Mycoplasma hominis; Ureaplasma parvum; Ureaplasma urealyticum | ||
| Liquid based cytology specimens; Urine | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs | Chlamydophila pneumoniae; Legionella pneumophila; Mycoplasma pneumoniae | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Blastocystis spp.; Cryptosporidium spp.; Dientamoeba spp.; Entamoeba histolytica; Giardia lamblia |
| Genital swabs | Trichomonas vaginalis | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Bronchoalveolar lavage; Nasal swabs; Nasopharyngeal and throat swab; Sputum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Combined nose and throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| General swabs; Genital swabs | Herpes simplex virus (HSV); Varicella zoster virus (VZV) | |
| Liquid based cytology specimens | Human papilloma virus (HPV) | |
| Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs; Throat wash | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) A/B | |
| Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV); Rhinovirus | ||
| Nasal swabs; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Plasma; Serum | Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA |
Molecular Genetics
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | Factor V Leiden; Haemochromatosis; Lactate persistence gene; Methylenetetrahydrofolate reductase (MTHFR); Prothrombin variant |
| Extracted DNA | JAK2 genotyping | |
| Dihydropyrimidine dehydrogenase (DPYD) genotyping | ||
| Nucleic acid analysis for specific variants; Thiopurine methyltransferase (TPMT) genotyping | ||
| HLA-B locus typing; HLA-DB locus typing; HLA-DR locus typing; Nucleic acid analysis for specific variants | ||
| UGT1A1 genotyping | ||
| Fragile X syndrome (FRAXA); UGT1A1 genotyping | ||
| Cystic fibrosis | ||
| HLA-B locus typing; HLA-DB locus typing; HLA-DR locus typing; Nucleic acid analysis for specific variants | ||
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted panels for inherited (germline) DNA/RNA changes | Extracted DNA | Cytochrome P450 pharmacogenomic studies; Nucleic acid analysis for specific variants |
| Molecular genetics - Bioinformatic analysis | DNA sequences | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
| Molecular genetics - DNA extraction | Blood | Viable DNA |
| Viable DNA | ||
| Viable DNA for sequencing | ||
| Blood; Buccal swabs | Viable DNA | |
| Molecular genetics - DNA fragment size analysis | Fluorescent-labelled DNA sequencing reaction product | Cystic fibrosis; DNA fragment size determination; Fragile X; Triple repeat analysis; UGT1A1 genotyping; Y chromosome microdeletion |
| MLPA products | DNA fragment size determination | |
| Molecular genetics - DNA sequencing | Blood; Extracted DNA | Sequenced DNA utilising massively parallel sequencing technologies |
| Extracted DNA | Sequenced DNA by Sanger sequencing | |
| Molecular genetics - Estimation of risk of inheritance of an unknown mutation (Bayesian and linkage calculations) | Extracted DNA | Spinal muscular atrophy |
| Cystic fibrosis; Estimation of risk | ||
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Blood | Chronic myeloid leukaemia (CML) |
| Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Extracted DNA | Spinal muscular atrophy; α-Thalassaemia |
| Cystic fibrosis | ||
| Fragile X syndrome (FRAXA) | ||
| Spinal muscular atrophy | ||
| Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes | Extracted DNA | Spinal muscular atrophy |
| Familial Mediterranean fever; Hereditary angioedema; Tumour necrosis factor receptor associated periodic syndrome (TRAPS) | ||
| Fragile X syndrome (FRAXA) | ||
| Cystic fibrosis | ||
| Spinal muscular atrophy; α-Thalassaemia | ||
| Molecular genetics - Non-invasive prenatal (genetic) screening | Maternal blood | Aneuploidy for chromosomes X and Y; Jacobs syndrome (XYY); Kleinfelters syndrome (XXY); Rare autosome aneuploidy and segmental genomic imbalances; Trisomy 13, trisomy 18, trisomy 21; Trisomy X; Turners syndrome (SCA:XO) |
| Molecular genetics - Predictive genetic testing - Targeted genes | Blood | Cystic fibrosis; Inherited cancer syndromes |
| Extracted DNA | Spinal muscular atrophy | |
| Hereditary angioedema | ||
| Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changes | Blood | Cystic fibrosis; Familial hypercholesterolemia; Hereditary breast and ovarian syndrome; Hereditary colorectal cancer; Inherited cancer syndromes |
| Molecular genetics - Screening for an unknown mutation - Targeted genes | Blood; Extracted DNA | Ataxia telangiectasia (Louis Bar syndrome); Familial Mediterranean fever; Hereditary angioedema; Inherited cancer syndromes; Inherited disorders; Li-Fraumeni syndrome; Macrocephaly PTEN gene mutation; PTEN hamartoma tumour syndrome (PHTS); Peutz-Jeghers syndrome; Tumour necrosis factor receptor associated periodic syndrome (TRAPS) |
| Extracted DNA | α-Thalassaemia | |
| Cystic fibrosis; Familial Mediterranean fever; Hereditary angioedema; Tumour necrosis factor receptor associated periodic syndrome (TRAPS) | ||
| Molecular genetics - Screening for an unknown mutation - Targeted panels for inherited (germline) DNA/RNA changes | Blood; Extracted DNA | Ataxia telangiectasia (Louis Bar syndrome); Familial Mediterranean fever; Familial hypercholesterolemia; Hereditary colorectal cancer; Inherited cancer syndromes; Inherited disorders; Li-Fraumeni syndrome; Macrocephaly PTEN gene mutation; PTEN hamartoma tumour syndrome (PHTS); Peutz-Jeghers syndrome |
Prenatal Testing
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 May 2023
Last Activity Date
02 Jun 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation of maternal markers to detect foetal abnormality | Serum | Free β-human chorionic gonadotropin (free β-hCG); Oestriol - Unconjugated; Placental growth factor (PGF, PLGF); Pregnancy associated plasma protein A (PAPP-A); α-Fetoprotein (AFP) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2178
Site No.
2171
Print date
21 Jan 2022
END OF SCOPE